References
- Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH. Early prenatal diagnosis of triploidy. Am J Obstet Gynecol. 1997; 176: 550–4
- Benn PA, Gainey A, Ingardia CJ, Rodis JF, Egan JF. Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement. Prenat Diagn. 2001; 21: 680–6
- Zaragoza MV, Surti U, Redline RW, Millie E, Chakravarti A, Hassold TJ. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet. 2000; 66: 1807–20
- McFadden DE, Kalousek DK. Two different phenotypes of fetuses with chromosomal triploidy: correlation with parental origin of the extra haploid set. Am J Med Genet. 1991; 38: 535–8
- McFadden DE, Kwong LC, Yam IY, Langlois S. Parental origin of triploidy in human fetuses: evidence for genomic imprinting. Hum Genet. 1993; 92: 465–9
- McFadden DE, Langlois S. Parental and meiotic origin of triploidy in the embryonic and fetal periods. Clin Genet. 2000; 58: 192–200
- Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10–14 weeks of gestation. Prenat Diagn. 2000; 20: 495–9
- Baumer A, Balmer D, Binkert F, Schinzel A. Parental origin and mechanisms of formation of triploidy: a study of 25 cases. Eur J Hum Genet. 2000; 8: 911–7
- Yaron Y, Ochshorn Y, Tsabari S, Shira AB. First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin. Prenat Diagn. 2004; 24: 445–50
- Uchida IA, Freeman VC. Triploidy and chromosomes. Am J Obstet Gynecol. 1985; 151: 65–9
- Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS, Wilson CC. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet. 1982; 46: 223–31
- Chasen ST, Kalish RB, Chervenak FA. Gestational age at abortion: the impact of first-trimester risk assessment for aneuploidy. Am J Obstet Gynecol. 2006; 195: 839–42
- Niemann I, Hansen ES, Sunde L. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Gynecol Oncol. 2007; 104: 411–5
- Barsoom MJ, McEntaffer A, Fleming A, Nipper HC. Marked abnormal quadruple screen in a patient with severe preeclampsia at 20 weeks with a triploid fetus. J Matern Fetal Neonatal Med. 2006; 19: 443–4